×

Valeant meltdown under scrutiny

8:15 AM ET Tue, 7 June 2016

Bethany McLean, Vanity Fair, discusses her in-depth expose of the ongoing saga at the pharmaceutical company which is currently under investigation for massive price hikes on lifesaving drugs.